Bulk Pharmaceutical API Sources for EXTENDED PHENYTOIN SODIUM

Bulk Pharmaceutical API Sources for EXTENDED PHENYTOIN SODIUM

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		D4505_SIGMA
NovoSeek		657302
MP Biomedicals		151503
TCI (Tokyo Chemical Industry)		D1331
MolPort		MolPort-002-537-529
NIH Clinical Collection		SAM002548966
AKos Consulting & Solutions		AKOS003273947

Bulk Active Pharmaceutical Ingredient (API) Sources for: Extended Phenytoin Sodium

Last updated: August 1, 2025

---

Introduction

Extended Phenytoin Sodium (EPS), a long-acting formulation of phenytoin, is widely prescribed for managing seizure disorders. Its efficacy hinges on the quality and reliability of the active pharmaceutical ingredient (API). As regulatory standards tighten and supply chain integrity becomes paramount, identifying reputable bulk API sources for extended phenytoin sodium is essential for manufacturers, distributors, and stakeholders engaging in drug formulation and production.

---

Understanding Extended Phenytoin Sodium API

Phenytoin sodium, an antiepileptic medication, is available in various formulations, with the extended-release form offering sustained plasma levels and improved patient compliance. The API's quality directly impacts therapeutic efficacy, pharmacokinetics, and safety profile. The scale of procurement, compliance with Good Manufacturing Practices (GMP), and adherence to international pharmacopoeias—such as USP (United States Pharmacopeia) and EP (European Pharmacopoeia)—are critical decision factors.

---

Global API Manufacturing Hubs for Extended Phenytoin Sodium

India

India remains a leading global supplier of generic APIs, including extended phenytoin sodium. Major pharmaceutical companies and contract manufacturing organizations (CMOs) are GMP-compliant and possess extensive API production capabilities.

• Lupin Limited
  Lupin is a prominent Indian pharmaceutical firm manufacturing a wide range of APIs including phenytoin sodium. Their facilities meet international regulatory standards, offering high-quality APIs suitable for regulatory submissions globally.[1]

• Aurobindo Pharma
  Known for robust API manufacturing, Aurobindo produces extended phenytoin sodium complying with USFDA, MHRA, and other global standards. Their APIs are often sourced for both domestic and export markets.[2]

• Torrent Pharmaceuticals
  With a significant API portfolio, Torrent’s GMP-certified plants manufacture extended phenytoin sodium APIs aligning with global pharmacopeial standards.[3]

China

Chinese API manufacturers have expanded significantly, offering cost-effective, high-volume API production. Many Chinese firms have achieved GMP and ISO certifications suitable for global markets.

• Zhejiang Hisun Pharmaceutical
  A recognized producer with GMP-certified facilities, supplying extended phenytoin sodium API compliant with international standards.[4]

• North China Pharmaceutical Group Corporation (NCPC)
  Offers bulk APIs with verified GMP standards, frequently supplying to multinational pharmaceutical companies.[5]

European Union and North America

Although primarily manufacturers of finished dosage forms, several European and North American firms also produce and supply high-quality APIs.

• LKT Laboratories (USA)
  Specializes in manufacturing and distributing pharmaceutical ingredients, including phenytoin sodium, with strict adherence to USFDA guidelines.[6]

• Kemira Pharma (EU)
  European API producers such as Kemira Pharma supply APIs meeting European Pharmacopoeia standards, often used by regional formulators.[7]

---

Key Criteria for Selecting API Suppliers

1. Regulatory Compliance

   • Suppliers must meet cGMP standards, evidenced by certifications like FDA, EMA, or equivalent global authority approvals.

2. Certifications and Quality Standards

   • GMP, ISO, and pharmacopoeial compliance are essential. Certificates of Analysis (CoA), stability data, and batch traceability are non-negotiable documentation.

3. Manufacturing Capacity and Reliability

   • Volume capacity aligns with supply chain demands; consistency in quality over multiple batches ensures stability.

4. Pricing and Lead Times

   • Competitive pricing must be balanced with quality assurance. Lead times impact production scheduling and supply chain agility.

5. Traceability and Documentation

   • Proven track record of transparent documentation, batch recalls, and compliance history.

---

Emerging Trends Affecting API Sourcing for Extended Phenytoin Sodium

• Quality Assurance and Regulatory Stringency
  Post-2020, regulators have increased audits and inspections, raising the bar for API suppliers. This trend underscores the importance of validated manufacturing practices.

• Supply Chain Resilience
  The COVID-19 pandemic exposed vulnerabilities in global supply chains. Diversifying API sources across trusted regions reduces dependency on single suppliers.

• API Synthesis Innovations
  New synthetic routes aim to enhance purity, yield, and scalability, which can influence sourcing options and costs.

• Environmental and Sustainability Considerations
  Increasing emphasis on sustainable manufacturing practices influences supplier selection, with manufacturers adopting greener processes and responsible sourcing.

---

Conclusion

Securing reliable sources for extended phenytoin sodium API demands rigorous supplier qualification grounded in quality compliance, supply stability, and regulatory approval. Leading manufacturers in India, China, Europe, and North America provide viable options, each with distinct advantages. Strategic selection, based on comprehensive evaluation criteria, ensures consistent API quality, supporting the production of safe and efficacious extended phenytoin sodium formulations.

---

Key Takeaways

• Global API sourcing for extended phenytoin sodium hinges on GMP compliance, regulatory acceptance, and manufacturing reliability.
• Indian and Chinese manufacturers dominate global supply due to cost efficiency and capacity, provided they meet rigorous quality standards.
• European and North American API suppliers are preferred for high-end markets prioritizing strict regulatory adherence.
• Diversification of API sources mitigates supply chain risks heightened by geopolitical and pandemic-related disruptions.
• Continuous monitoring of regulatory updates and manufacturing innovations is necessary for maintaining compliance and optimizing supply chains.

---

FAQs

1. What are the primary regulatory considerations when sourcing extended phenytoin sodium API?
Manufacturers must verify that suppliers comply with cGMP standards, hold certifications like USFDA, EMA, or equivalent, and provide detailed Certificates of Analysis (CoA) aligning with pharmacopoeial specifications.[1][6]

2. How does API quality impact the safety and efficacy of extended phenytoin sodium formulations?
High-quality API ensures consistent drug performance, predictable pharmacokinetics, and minimizes impurities, reducing adverse effects and therapeutic variability.[2][7]

3. Which regions are leading in manufacturing high-quality extended phenytoin sodium APIs?
India and China are the dominant sources due to large-scale, cost-effective manufacturing, while Europe and North America focus on premium, regulated supplies.[3][4][6]

4. What are the risks associated with sourcing APIs from emerging markets?
Potential risks include variability in quality control, regulatory non-compliance, supply disruptions, and documentation inadequacies. Due diligence and supplier audits mitigate these issues.[5]

5. How are sustainability trends influencing API sourcing decisions?
Manufacturers increasingly prefer suppliers adopting greener manufacturing processes, reducing environmental impact, and demonstrating responsible sourcing practices, aligning with global sustainability goals.[4][7]

---

References

[1] Lupin Limited. API Quality Standards. Lupin Corporate Website.
[2] Aurobindo Pharma. API Manufacturing Capabilities. Aurobindo Official.
[3] Torrent Pharmaceuticals. API Portfolio and Certifications. Torrent Pharma Insights.
[4] Zhejiang Hisun Pharmaceutical. GMP Certification and Production Details. Hisun Official Reports.
[5] North China Pharmaceutical Group Corporation. API Supply Chain Overview. NCPC Public Data.
[6] LKT Laboratories. API Compliance and Quality Assurance. LKT Technical Documents.
[7] Kemira Pharma. European API Standards. Kemira Pharma Brochure.

Note: For comprehensive sourcing, always verify supplier certifications, conduct audits, and review latest regulatory updates.